Back to Press Room
Press Release

Freddy Gnangnon unlocks the breast cancer challenge in Benin with innovative solutions

Freddy Gnangnon, a researcher at the Institute for Research and Development, revealed that 65% of breast cancer cases in Benin are diagnosed at an advanced stage. His thesis, defended in 2024, proposes concrete solutions to improve screening and access to care in the country, an urgent public health issue.

Breast cancer is a major public health challenge in Benin, where 65% of cases are diagnosed late. This alarming situation results from limited access to care, a lack of awareness, and insufficient coordination. Women, particularly in rural areas, face obstacles in obtaining early diagnosis, raising questions about health equity.

Freddy Gnangnon's research has identified key prognostic factors and proposes an integrated approach to improve early detection. By analyzing health infrastructures, he highlighted the need to increase human and material resources. The findings emphasize that improving health services could significantly reduce breast cancer mortality rates.

The implications of this research are strategic for policymakers. Improving screening and access to care represents an opportunity for investors in the health sector in Benin. It is recommended to initiate pilot projects and collaborate with local stakeholders to ensure community buy-in and maximize the impact of interventions.

« "About 65% of breast cancer cases in Benin are diagnosed at an advanced stage, highlighting the urgency of improving screening and access to care," says Freddy Gnangnon. »

« "This research highlights concrete solutions to transform the health landscape in Benin, a crucial issue for policymakers and investors," asserts the Lektaris team. »

About Lektaris

À propos de Lektaris : Plateforme d'intelligence territoriale sur le Bénin et l'Afrique de l'Ouest, Lektaris transforme les résultats de la recherche académique en briefs exécutifs opérationnels pour les décideurs, investisseurs et la diaspora. L'accès aux analyses complètes est disponible via abonnement annuel sur https://lektaris.com.

Press contact: contact@lektaris.com